Virtu Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Virtu Financial’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-29,755	Closed	-$1.09M	–	1913
2018 Q4	$1.09M	Buy	+29,755	New	+$1.27M	0.06%	255
2018 Q3	–	Sell	-34,773	Closed	-$1.5M	–	2294
2018 Q2	$1.5M	Sell	34,773 -9,606	-22%	-$403K	0.09%	243
2018 Q1	$1.86M	Buy	44,379 +7,036	+19%	+$307K	0.1%	185
2017 Q4	$1.62M	Buy	37,343 +24,631	+194%	+$1.05M	0.09%	257
2017 Q3	$541K	Buy	+12,712	New	+$539K	0.03%	861
2017 Q1	–	Sell	-13,572	Closed	-$531K	–	604
2016 Q4	$531K	Sell	13,572 -19,866	-59%	-$808K	0.06%	241
2016 Q3	$1.48M	Buy	+33,438	New	+$1.52M	0.25%	88
2016 Q1	–	Sell	-18,014	Closed	-$922K	–	533
2015 Q4	$922K	Buy	+18,014	New	+$918K	0.13%	154

Other funds holding XPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Virtu Financial's XPH Position: Q1 2019 in Review

Virtu Financial sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2019, closing a stake of 29,755 shares — an estimated $1.09M sold.

Virtu Financial first reported a position in XPH in Q4 2015 and held it in 8 quarters. The position peaked at $1.86M in Q1 2018. 80 funds tracked by Wall St. Rank hold XPH as of Q1 2019.

Virtu Financial reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
Virtu Financial sold 29,755 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2019, an estimated $1.09M.
Virtu Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2015 and held it in 8 quarters.
Virtu Financial's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.86M in Q1 2018.
80 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2019.

Based on Virtu Financial's 13F filing for Q1 2019, filed 12 Apr 2019.